Marrone Bio Innovations Announces Chief Financial Officer to Retire From the Company

Marrone Bio Innovations logo

DAVIS, Calif., Nov. 7, 2013 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that its Chief Financial Officer, Don Glidewell, has determined to retire from the Company. To facilitate a smooth transition, Mr. Glidewell has agreed to remain as Chief Financial Officer for up to five months while the Company conducts a search for a successor chief financial officer.

"Don has made significant contributions to MBI and has helped the Company grow into an industry-leading, publicly- traded company," said Pam Marrone, founder and chief executive officer. "We are grateful to Don for his many contributions, dedication and hard work, and are pleased that he will continue to serve as our chief financial officer during the transition period."

Mr. Glidewell added, "I am proud of what the company has accomplished during my tenure and of my role in putting the company on a financially-stable footing. MBI continues to make progress toward transforming the pest management industry and I remain excited about the future of the company. It was a very difficult decision to leave and I am committed to ensuring a smooth transition to a new CFO."

Forward-Looking Statements

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to leveraging our platform to penetrate new markets and the results from the field trials. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the timing of and costs associated with the launch of products, the difficulty in predicting the timing or outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-Q that the Company filed with the Securities and Exchange Commission on September 13, 2013.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (Nasdaq:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets. Our effective and environmentally responsible biopesticides help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a rapid proprietary discovery and development platform and a robust pipeline of pest management and plant health candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

CONTACT: Investor Contact The Blueshirt Group David Niederman +1-415-489-2189 ir@marronebio.com

Source:Marrone Bio Innovations